Skip to content

Inspection Record

CoreRX Inc. — FDA 483 Findings

US FDAInspected 2025-03-20Published 2026-10-20 5 findingsQuality unit oversightMaterial and supplier controlEquipment and facilityDeviation, CAPA, and investigation

Inspectors Peng Zhou · Thai D TruongThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Quality unit oversight

The responsibilities and procedures applicable to the quality control unit are not in writing.

2Material and supplier control

Written procedures are not followed for the storage of components and dnig product Specifically, MO) MWD A.

3Equipment and facility

Buildings used in the manufacture, in a clean and sanitary condition.

4Deviation, CAPA, and investigation

There is a failure to thoroughly review any unexplained discrepancy and the failure of a batch or any of its components to meet any of its specifications whether or not the batch has been already distributed.

5Equipment and facility

Written procedures are not established and followed for the cleaning and maintenance of equipment, including ,used in the manufacture, jof a drug product.

Similar findings at other companies

GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.

A record as of the US FDA document published on 2026-10-20. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.

CoreRX Inc. company profile — full historyAll US FDA findings US FDA documents, 2026 Go to Findings search
Linked from (backlinks)
Briefs that featured this document
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.